LIVN

LIVN

LivaNova PLC Ordinary Shares

$46.630+-0.000 (-0.000%)

Prix en Temps Réel

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$46.630

Haut

$46.630

Bas

$46.630

Volume

0.67M

Fondamentaux de l'Entreprise

Statistiques de Trading

Actualités Connexes

BusinessWire

CORE-VNS Study Further Validates Effectiveness of LivaNova's VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy

Long-term, real-world evidence demonstrates early and lasting outcomes of adjunctive VNS Therapy on severe focal seizures LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced

Voir plus
CORE-VNS Study Further Validates Effectiveness of LivaNova's VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy
BusinessWire

LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression

Final critical papers on RECOVER clinical study data accepted, supporting the Company's submission for coverage reconsideration Strong 24-month top-line data for RECOVER clinical study demonstrates durability of VNS

Voir plus
LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression
Analyst Upgrades

Wolfe Research Upgrades LivaNova to Outperform, Announces $60 Price Target

Wolfe Research analyst Mike Polark upgrades LivaNova from Peer Perform to Outperform and announces $60 price target.

Voir plus
Wolfe Research Upgrades LivaNova to Outperform, Announces $60 Price Target